Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Record identifier

TN_cdi_proquest_miscellaneous_1751215096

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215096

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Full title

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2012, Vol.13 (10), p.983-992

Record Identifier

TN_cdi_proquest_miscellaneous_1751215096

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_miscellaneous_1751215096

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215096

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card